June 4, 2026

Beyond ‘Grifters and True Believers’: Why Labelling Vaccine Skeptics Fails Public Health

 Beyond ‘Grifters and True Believers’: Why Labelling Vaccine Skeptics Fails Public Health

The Echo Chamber of ‘Wrong’

When Stanley Plotkin, a 93-year-old titan of vaccinology, recently lamented that he’s “beginning to regret having lived so long—because we’re going downhill,” he articulated a frustration many in public health share. The surge of anti-vaccine arguments, seemingly pervasive online, often feels like a modern malady. Yet, as Thomas Levenson outlines in his new book, these sentiments are not novel; they have haunted vaccination efforts since the 18th century, a time when infectious disease tragically claimed roughly 40 percent of babies before their fifth birthday.

Levenson’s framework categorizes opponents into “True Believers, Grifters, and Cynics,” implying their arguments are simply “wrong, bad, and intolerable.” This diagnostic neatly packages dissent, offering a convenient, if ultimately superficial, explanation for why some people reject established medical consensus. But this rhetorical simplification, labeling all skepticism as misguided or malicious, has become a self-reinforcing loop, allowing public health institutions to evade deeper self-examination.

Dismissing all vaccine skeptics as merely “true believers, grifters, or cynics” is a convenient rhetorical shortcut that absolves institutions of their role in eroding public trust. It creates an echo chamber where complex social anxieties are reduced to simple moral failings, hindering genuine dialogue and perpetuating the very mistrust it seeks to combat. The conversation remains trapped in a binary of ‘right’ versus ‘wrong’, rather than acknowledging the multifaceted reasons individuals might distrust authorities or information.

Trust, Transparency, and the Grifter Economy

The existence of “grifters” and “cynics” in the anti-vaccine landscape is undeniable; opportunists will always exploit societal vulnerabilities. However, their ability to thrive is directly proportional to existing gaps in institutional credibility and failures in public health communication. In an era of rampant misinformation, the vacuum left by perceived official obfuscation is swiftly filled by alternative narratives, no matter how specious.

This framing—categorizing the opposition rather than dissecting its origins—benefits established powers. It allows public health bodies to maintain a clear “us vs. them” narrative, simplifying a profoundly complex social problem into a manageable issue of countering a fringe, ill-intentioned minority. The underlying incentive here is clear: it justifies a top-down, often paternalistic, communication strategy without requiring introspection into systemic issues that might feed skepticism, such as pharmaceutical industry practices or historical medical abuses.

When pharmaceutical companies historically concealed data, or governments engaged in unethical medical trials, they inadvertently laid the groundwork for future distrust. The public, especially in regions with a history of exploitation, remembers. Labelling current skepticism as irrational ignores these historical precedents and fails to rebuild the information integrity crucial for widespread acceptance. It’s a communication approach rooted in correction, not connection.

A Global Reckoning for Public Health Communication

The persistence of vaccine hesitancy isn’t solely a Silicon Valley or Western phenomenon; it’s a global challenge with local nuances. My years covering technology from Geneva, Singapore, and London have repeatedly shown that US-centric analyses often miss the structural implications rooted in diverse socio-economic and colonial histories. In many parts of the world, distrust in public health initiatives is not simply a matter of digital literacy or conspiracy theories; it is a legacy of unequal access to care, medical exploitation, and a profound skepticism towards foreign-led interventions.

Consider regions where medical aid has, at times, been tied to geopolitical agendas or where drug trials have disproportionately affected vulnerable populations. This context is fertile ground for suspicion, making the simple “wrong, bad, intolerable” categorization woefully inadequate. It necessitates a nuanced approach to vaccine hesitancy that addresses historical grievances and present-day inequities, rather than merely broadcasting scientific facts from a position of assumed authority.

The current challenge, particularly with novel pathogens and rapid vaccine development, demands a fundamental shift. We are well past the era of simply declaring a medical consensus and expecting universal adherence. The observable impact of this dismissive strategy is manifest in fragmented public response to health crises, persistent outbreaks in developed nations, and a growing political polarization around scientific facts. A genuine commitment to transparent, empathetic, and culturally competent communication, rather than just categorizing dissent, is the only sustainable path forward.

Arjun Vedanta

https://techticle.com

Arjun Vedanta is a technology journalist and analyst covering global tech infrastructure, artificial intelligence, and the economics of the digital economy. Writing from outside Silicon Valley, he focuses on what the industry's biggest stories actually mean — not just what happened. His work examines the structural forces, hidden incentives, and second-order consequences that most tech coverage leaves on the table.